Cellectis (CLLS) Earnings Date, Estimates & Call Transcripts $1.15 -0.05 (-4.17%) Closing price 04:00 PM EasternExtended Trading$1.12 -0.02 (-2.17%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cellectis Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 5EstimatedActual EPS (Mar. 13) -$0.16 Missed By -$0.22 Consensus EPS (Mar. 13) $0.06 Cellectis announced Q4 2024 earnings on March 13, 2025, reporting an EPS of -$0.16, which missed the consensus estimate of $0.06 by $0.22. Quarterly revenue was reported to be $33.22 million, above analyst estimates of $5.90 million. With a trailing EPS of -$0.83, Cellectis' earnings are expected to decrease next year, from ($0.46) to ($0.52) per share. Conference CallConference Call TranscriptCLLS Upcoming EarningsCellectis' next earnings date is estimated for Monday, May 5, 2025, based off prior year's reporting schedules. Get Cellectis Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cellectis and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCLLS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLLS Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Cellectis Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.46) EPSNext Year EPS Consensus Estimate: ($0.52) EPS Remove Ads Cellectis Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/5/2025(Estimated)-------3/13/2025Q4 2024$0.06-$0.16 -$0.22-$0.15$5.90M$33.22M11/4/2024Q3 2024-$0.20-$0.23 -$0.03-$0.23$5.00M$18.05M8/6/2024Q2 2024-$0.33-$0.28+$0.05-$0.28$6.00M$9.50M5/28/2024Q1 2024--$0.15 -$0.15-$0.15-$6.50M4/29/2024Q4 2023--$0.64 -$0.64-$0.64-$1.99M11/6/2023Q3 2023-$0.36-$0.31+$0.05-$0.31$4.03M$1.64M8/3/2023Q2 2023-$0.38-$0.14+$0.24-$0.09$7.80M$2.00M5/4/2023Q1 2023-$0.30-$0.58 -$0.28-$0.58$9.30M$3.56M Cellectis Earnings - Frequently Asked Questions When is Cellectis's earnings date? Cellectis has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on CLLS's earnings history. Did Cellectis beat their earnings estimates last quarter? In the previous quarter, Cellectis (NASDAQ:CLLS) missed the analysts' consensus estimate of $0.06 by $0.22 with a reported earnings per share (EPS) of ($0.16). Learn more on analysts' earnings estimate vs. CLLS's actual earnings. How can I listen to Cellectis's earnings conference call? The conference call for Cellectis's latest earnings report can be listened to online. Listen to Conference Call How can I read Cellectis's conference call transcript? The conference call transcript for Cellectis's latest earnings report can be read online. Read Transcript How much revenue does Cellectis generate each year? Cellectis (NASDAQ:CLLS) has a recorded annual revenue of $41.51 million. How much profit does Cellectis generate each year? Cellectis (NASDAQ:CLLS) has a recorded net income of -$101.06 million. CLLS has generated -$0.83 earnings per share over the last four quarters. What is Cellectis's EPS forecast for next year? Cellectis's earnings are expected to decrease from ($0.46) per share to ($0.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies COMPASS Pathways Earnings Date Atyr PHARMA Earnings Date Compass Therapeutics Earnings Date Lifecore Biomedical Earnings Date Olema Pharmaceuticals Earnings Date Candel Therapeutics Earnings Date ProKidney Earnings Date 2seventy bio Earnings Date Bright Minds Biosciences Earnings Date Atea Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go Higher Remove Ads This page (NASDAQ:CLLS) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLLS Stock Free CLLS Stock Alerts